Table 2 Clinical characteristics of the study participants
Characteristics | Intervention, n (%) (N=153) | Control, n (%) (N=149) | p-value |
|---|---|---|---|
Smoking | |||
Present | 28(18.3) | 26(17.5) | 0.85 |
Absent | 125(81.7) | 123(82.5) | |
Hypertension | |||
Present | 64 (41.8) | 78 (52.3) | 0.07 |
Absent | 89 (58.2) | 71 (47.7) | |
Cardiac disease | |||
Present | 22 (14.4) | 27 (18.1) | 0.39 |
Absent | 131 (85.6) | 122 (81.9) | |
Duration of diabetes in years | |||
<1 | 20 (13.1) | 22 (14.8) | 0.56 |
1-5 | 49 (32.0) | 41 (27.5) | |
5-10 | 30 (19.6) | 38 (25.5) | |
>10 | 54 (35.3) | 48 (32.2) | |
Diabetic macular edema | |||
Present | 44 (28.8) | 53 (35.6) | 0.21 |
Absent | 109 (71.2) | 96 (64.4) | |
BCVA right eye | |||
6/6- 6/18 | 106 (69.3) | 93 (62.4) | 0.33 |
6/18-6/60 | 27 (17.6) | 26 (17.5) | |
6/60- 3/60 | 11 (7.2) | 13 (8.7) | |
3/60- NPL | 9 (5.9) | 17 (11.4) | |
BCVA left eye | |||
6/6- 6/18 | 105 (68.6) | 96 (64.4) | 0.67 |
6/18-6/60 | 36 (23.5) | 35 (23.4) | |
6/60- 3/60 | 6 (3.9) | 9 (6.1) | |
3/60- NPL | 6 (3.9) | 9 (6.1) | |
BCVA person wise best eye | |||
6/6- 6/18 | 116 (75.8) | 75 (69.2) | 0.3 |
6/18-6/60 | 28 (18.3) | 28 (18.8) | |
6/60- 3/60 | 6 (3.9) | 9 (6.0) | |
3/60- NPL | 3 (2.0) | 9 (6.0) | |